News & Media


November 28, 2022

Trends in AAV development and manufacturing for gene therapies

Following pre-clinical and clinical success, adeno-associated viral vectors (AAVs), have become a leading tool for gene delivery in the treatment...

News & Media

July 11, 2022

Optimizing Process Development Early – A critical factor in successful viral vector scale up and large scale manufacture

John Ketz and Denis Kole speak with Brandy Sargent on The Cell Culture Dish podcast about viral vector production, including current manufacturing challenges, navigating the road to commercialization, and successful scale up strategies.


February 28, 2022

Andelyn Biosciences Observes Rare Disease Day

Observed every year on the last day in February, Rare Disease Day works to raise awareness for rare diseases and...

News & Media

February 14, 2022

Reliability and the Future of Cell & Gene Therapies

Mayo Pujols, CEO of Andelyn Biosciences, discusses how Cell & Gene companies are focusing on reliability and predictability to further advance this innovative therapy.


February 11, 2022

Andelyn’s Women in Science

Every day here at Andelyn Biosciences is Women in Science Day! We are proud that 50% of our scientists on...


February 8, 2022

Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing

Gene therapies offer an unprecedented ability to treat — and even cure — genetic diseases, and their potential spanning diverse...

News & Media

January 13, 2022

FDA Accepts GMP Plasmid DMF and Capacity Expansion Enabling Andelyn Biosciences to Offer Faster Gene Therapy Development

COLUMBUS, OH, January 13, 2022 – Andelyn Biosciences, a pioneering cell and gene therapy CDMO born out of Nationwide Children’s Hospital, today...

News & Media

November 22, 2021

Nationwide Children’s Spinoff Andelyn Biosciences to Open New Lab in Dublin

Andelyn Biosciences has set its sights on Dublin for one of two new labs for the gene therapy company.


November 11, 2021

Leveraging Partnerships and a Unique History to Address Supply Chain and Capacity Challenges in Gene Therapy Manufacturing

Andelyn Biosciences has established a unique network of industry experts across the entire development and commercialization spectrum. In addition to...


October 22, 2021

Coping with a Talent Shortage and Talent War in Cell and Gene Therapy

Andelyn Biosciences is building the best cell and gene therapy team in spite of a talent shortage and competitive talent...

Connect Here With Our Business Team